Polycythemia Vera (PV)
Hematology
3
Pipeline Programs
1
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
2
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
PharmaEssentiaMA - Burlington
3 programs1
2
P1101Phase 31 trial
P1101Phase 31 trial
P1101Phase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
PharmaEssentiaP1101
PharmaEssentiaP1101
PharmaEssentiaP1101
Clinical Trials (3)
A Study to Evaluate P1101 in Japanese PV Patients
Start: Oct 2023Est. completion: Jul 2024
Phase 3Completed
Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients
Start: Jan 2021Est. completion: Jun 2026
Phase 3Recruiting
Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply
Start: Dec 2019Est. completion: Mar 2021
Phase 2Completed
Related Jobs in Hematology
Délégué Médical LLC/Myélome (H/F) - secteurToulouse
Johnson & Johnson
Issy-les-Moulineaux, France
Yesterday
MSL Hematología L - Sur
Johnson & Johnson
Sevilla, Spain
Yesterday
Senior Manager – Strategy & Business Transformation
Johnson & Johnson
Mumbai, India
Yesterday
Sr. Director Marketing
Genetix Biotherapeutics
Somerville, Massachusetts, United States
4d ago
From $270K/yr
Key Account Specialist Hematology
Johnson & Johnson
Beirut, Lebanon
4d ago
Hematology Field Medical Director, non-MD
Pfizer
Remote
4d ago
$177K - $294K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials
1 companies competing in this space